CoChat

Unlocking the power of the microbiome for successful cancer immunotherapy

Open access
Clavijo-Salomon, Maria A, Trinchieri, Giorgio · 2025 · Journal for ImmunoTherapy of Cancer

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

In recent years, evidence has shown that the gut microbiome significantly influences responses to immunotherapy. This has sparked interest in targeting it to improve therapy outcomes and predictions of response and toxicity. Research has demonstrated that dysbiosis, often resulting from antibiotic use, can diminish the effectiveness of immune checkpoint inhibitors, and this lack of efficacy could be linked to systemic inflammation. Certain bacterial species have been identified as having beneficial and harmful effects on immunotherapy in the clinic. While a clear consensus has yet to emerge on the optimal species for therapeutic use, introducing a new microbiome into immunotherapy-refractory patients may boost their chances of responding to further treatment attempts. State-of-the-art interventions targeting the microbiome—such as fecal microbiota transplantation—are being assessed clinically for their safety and potential to enhance treatment outcomes, with promising results. Additionally, the microbiome has been leveraged for its power to predict clinical outcomes using machine learning, and surprisingly, its predictive capability is comparable to that of other described multi-biomarker clinical scores. Here, we discuss developing knowledge concerning the microbiome’s significance in cancer immunotherapy and outline future strategies for maximizing its potential in immuno-oncology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jitc-2024-011281

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The gut microbiome is a tool for predicting therapy response and patient stratification, as well as a target for therapeutic intervention. Microbiome data and other clinical biomarkers from large cohorts of cancer patients representative of diverse cancer types, therapy protocols, and geographical origins may be used to train machine learning models or to determine clinical scores for predicting responses to different immunotherapy protocols. This prediction is expected to become useful in stratifying patients for the probability of response to immunotherapy as single agents or as combination therapy with other agents. The prediction may also assist in deciding whether and which type of microbiome targeting co-therapy may be advisable. Created in Biorender.com.
Figure 1 The gut microbiome is a tool for predicting therapy response and patient stratification, as well as a target for therapeutic intervention. Microbiome data and other clinical biomarkers from large cohorts of cancer patients representative of diverse cancer types, therapy protocols, and geographical origins may be used to train machine learning models or to determine clinical scores for predicting responses to different immunotherapy protocols. This prediction is expected to become useful in stratifying patients for the probability of response to immunotherapy as single agents or as combination therapy with other agents. The prediction may also assist in deciding whether and which type of microbiome targeting co-therapy may be advisable. Created in Biorender.com.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 18

Metadata

Authors
Clavijo-Salomon, M. A., & Trinchieri, G.
Affiliations
National Cancer Institute (US)
Corresponding author
Trinchieri, Giorgio
Venue
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Published
2025-04
Volume
13
Issue
4
Pages
e011281
ISSN
2051-1426 (ISSN-L)
OpenAlex
W4409114112
Cited by
18
References
19
Citations by year
2026: 11 · 2025: 7
FWCI
5.37
Type
journal article
Language
en
Open access
Locations
  • Journal for ImmunoTherapy of Cancer (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Intramural Research Program, NCI. NIH (N/A)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Keywords
gut microbiota, cancer immunotherapy, immune checkpoint inhibitors, dysbiosis, antibiotic use, systemic inflammation, fecal microbiota transplantation, microbiota-targeted interventions, immunotherapy response prediction, machine learning prediction
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Humans, Immunotherapy, Neoplasms, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unlocking the power of the microbiome for successful cancer immunotherapy. https://app.cochat.ai/papers/10.1136/jitc-2024-011281
The paper
Clavijo-Salomon, M. A., & Trinchieri, G. (2025). Unlocking the power of the microbiome for successful cancer immunotherapy. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-011281

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.